Sinopharm Group Co ( (HK:1099) ) has shared an announcement.

Sinopharm Group has proposed a final ordinary cash dividend of RMB 0.69 per share for the financial year ended 31 December 2025, equivalent to HKD 0.79 per share based on an exchange rate of RMB 1 to HKD 1.15, with shareholder approval obtained on 18 June 2026. The company has set an ex-dividend date of 23 June 2026, a record date of 30 June 2026, and a payment date of 18 August 2026, and it detailed differentiated withholding tax treatments for various categories of non-resident and mainland investors accessing its H shares, clarifying after-tax entitlements and reinforcing transparency for its diverse shareholder base.

Sinopharm specified that non-resident enterprise and individual H-shareholders registered outside the PRC will generally face a 10% withholding tax on the final dividend, while mainland individual investors and securities investment funds holding H shares via Shanghai-Hong Kong or Shenzhen-Hong Kong Stock Connect will be subject to a 20% tax rate. By outlining these tax arrangements and the timetable for the dividend, the company provides greater certainty to investors regarding net distributions and compliance obligations, which may influence investor perception of its share attractiveness and post-tax yield, particularly for cross-border shareholders.

The most recent analyst rating on (HK:1099) stock is a Buy
with a HK$22.50 price target.
To see the full list of analyst forecasts on Sinopharm Group Co stock,
see the HK:1099 Stock Forecast page.